{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:32:31Z","timestamp":1793331151078,"version":"4.5.0"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":2658,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T00:00:00Z","timestamp":1539648000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Chronic kidney disease (CKD) is associated with morbidity and mortality in dogs. Plasma fibroblast growth factor-23 (FGF-23) concentration is an independent predictor of CKD progression and survival in cats and people with CKD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To investigate the relationship among FGF-23, parathyroid hormone (PTH), vitamin D metabolites, and other clinical variables with survival time in dogs with CKD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Animals<\/jats:title>\n                    <jats:p>Twenty-seven azotemic CKD dogs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Dogs were recruited prospectively into the study and followed until death or study conclusion. Dogs were International Renal Interest Society (IRIS) staged into stage 2 (n = 9), stage 3 (n = 12), and stage 4 (n = 6) CKD. Survival times were calculated from the date of study inclusion. Univariable Cox regression was used to assess variables associated with survival including body condition score (BCS), muscle condition score, hematocrit, creatinine, CKD stage, serum phosphorus, urine protein:creatinine ratio (UPC), calcium phosphorus product (CaPP), PTH, 25-hydroxyvitamin D, 1,25--dihydroxyvitamin D, and FGF-23 concentrations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Significant hazard ratios (hazard ratio; 95% confidence interval; P value) were as follows: BCS\u2009&amp;lt; 4\/9 (1.579; 1.003-2.282; P =\u2009.05), muscle atrophy (2.334; 1.352-4.030; P =\u2009.01), increased creatinine (1.383; 1.16-1.64; .01), hyperphosphatemia (3.20; 1.357-7.548; P =\u2009.005), increased UPC (3.191; 1.310-7.773; P =\u2009.01), increased CaPP (4.092; 1.771-9.454; P =\u2009.003), and increased FGF-23 (2.609; 1.090-6.240; P =\u2009.05). Survival times for each IRIS CKD stage were significantly different (P =\u2009.01).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Clinical Importance<\/jats:title>\n                    <jats:p>Multiple variables, including FGF-23, were associated with duration of survival in CKD dogs. FGF-23 could be a prognostic marker in dogs with CKD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/jvim.15322","type":"journal-article","created":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T07:31:17Z","timestamp":1539675077000},"page":"1977-1982","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":73,"title":["Factors associated with survival in dogs with chronic kidney disease"],"prefix":"10.1093","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5369-3152","authenticated-orcid":false,"given":"Adam J.","family":"Rudinsky","sequence":"first","affiliation":[{"name":"College of Veterinary Medicine, The Ohio State University Department of Veterinary Clinical Sciences, , Columbus, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M.","family":"Harjes","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, The Ohio State University Department of Veterinary Clinical Sciences, , Columbus, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Byron","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, The Ohio State University Department of Veterinary Clinical Sciences, , Columbus, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis J.","family":"Chew","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, The Ohio State University Department of Veterinary Clinical Sciences, , Columbus, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramiro E.","family":"Toribio","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, The Ohio State University Department of Veterinary Clinical Sciences, , Columbus, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Langston","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, The Ohio State University Department of Veterinary Clinical Sciences, , Columbus, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6505-8068","authenticated-orcid":false,"given":"Valerie J.","family":"Parker","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, The Ohio State University Department of Veterinary Clinical Sciences, , Columbus, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,11,1]]},"reference":[{"key":"2026021006404422700_jvim15322-bib-0001","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.2460\/javma.1999.214.09.1336","article-title":"Health status and population characteristics of dogs and cats examined at private veterinary practices in the United States","volume":"214","author":"Lund","year":"1999","journal-title":"J Am Vet Med Assoc"},{"key":"2026021006404422700_jvim15322-bib-0002","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.prevetmed.2010.01.007","article-title":"Disease surveillance and referral bias in the veterinary medical database","volume":"94","author":"Bartlett","year":"2010","journal-title":"Prev Vet Med"},{"key":"2026021006404422700_jvim15322-bib-0003","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1136\/vr.103059","article-title":"Incidence of and mortality from kidney disease in over 600,000 insured Swedish dogs","volume":"176","author":"Pelander","year":"2015","journal-title":"Vet Rec"},{"key":"2026021006404422700_jvim15322-bib-0004","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/jvim.14707","article-title":"Fibroblast growth Factor-23 concentration in dogs with chronic kidney disease","volume":"31","author":"Harjes","year":"2017","journal-title":"J Vet Intern Med"},{"key":"2026021006404422700_jvim15322-bib-0005","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/jvim.14653","article-title":"Association of Vitamin D Metabolites with parathyroid hormone, fibroblast growth Factor-23, calcium, and phosphorus in dogs with various stages of chronic kidney disease","volume":"31","author":"Parker","year":"2017","journal-title":"J Vet Intern Med"},{"key":"2026021006404422700_jvim15322-bib-0006","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1093\/ndt\/gfr076","article-title":"Vitamin D status and mortality in chronic kidney disease","volume":"26","author":"Pilz","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"2026021006404422700_jvim15322-bib-0007","doi-asserted-by":"crossref","first-page":"e016528","DOI":"10.1136\/bmjopen-2017-016528","article-title":"Associations of fibroblast growth factor 23, vitamin D and parathyroid hormone with 5-year outcomes in a prospective primary care cohort of people with chronic kidney disease stage 3","volume":"7","author":"Shardlow","year":"2017","journal-title":"BMJ Open"},{"key":"2026021006404422700_jvim15322-bib-0008","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1111\/jvim.13625","article-title":"Relationship between plasma fibroblast growth Factor-23 concentration and survival time in cats with chronic kidney disease","volume":"29","author":"Geddes","year":"2015","journal-title":"J Vet Intern Med"},{"key":"2026021006404422700_jvim15322-bib-0009","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1111\/j.1939-1676.2011.00805.x","article-title":"Association between body condition and survival in dogs with acquired chronic kidney disease","volume":"25","author":"Parker","year":"2011","journal-title":"J Vet Intern Med"},{"key":"2026021006404422700_jvim15322-bib-0010","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s10157-017-1468-8","article-title":"Anemia as a risk factor for all-cause mortality: obscure synergic effect of chronic kidney disease","volume":"22","author":"Sato","year":"2018","journal-title":"Clin Exp Nephrol"},{"key":"2026021006404422700_jvim15322-bib-0011","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.kint.2017.08.025","article-title":"Body composition is associated with clinical outcomes in patients with non-dialysis-dependent chronic kidney disease","volume":"93","author":"Lin","year":"2018","journal-title":"Kidney Int"},{"key":"2026021006404422700_jvim15322-bib-0012","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1939-1676.2008.0163.x","article-title":"Survival in cats with naturally occurring chronic kidney disease (2000-2002)","volume":"22","author":"Boyd","year":"2008","journal-title":"J Vet Intern Med"},{"key":"2026021006404422700_jvim15322-bib-0013","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.2460\/javma.245.10.1135","article-title":"Prognostic role of the product of serum calcium and phosphorus concentrations in dogs with chronic kidney disease: 31 cases (2008-2010)","volume":"245","author":"Lippi","year":"2014","journal-title":"J Am Vet Med Assoc"},{"key":"2026021006404422700_jvim15322-bib-0014","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2460\/javma.2005.226.393","article-title":"Evaluation of the association between initial proteinuria and morbidity rate or death in dogs with naturally occurring chronic renal failure","volume":"226","author":"Jacob","year":"2005","journal-title":"J Am Vet Med Assoc"},{"key":"2026021006404422700_jvim15322-bib-0015","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1939-1676.2006.tb02892.x","article-title":"Survival of cats with naturally occurring chronic renal failure is related to severity of proteinuria","volume":"20","author":"Syme","year":"2006","journal-title":"J Vet Intern Med"},{"key":"2026021006404422700_jvim15322-bib-0016","article-title":"Phosphatemia Management in the Treatment of Chronic Kidney Disease, a Roundtable Discussion","author":"Vetoquinol","year":"2006"},{"key":"2026021006404422700_jvim15322-bib-0017","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1159\/000479300","article-title":"Fibroblast growth factor 23 predicts mortality and end-stage renal disease in a Canadian Asian population with chronic kidney disease","volume":"137","author":"Jialal","year":"2017","journal-title":"Nephron"},{"key":"2026021006404422700_jvim15322-bib-0018","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/jvim.12036","article-title":"Fibroblast growth factor 23 (FGF-23) concentrations in cats with early nonazotemic chronic kidney disease (CKD) and in healthy geriatric cats","volume":"27","author":"Finch","year":"2013","journal-title":"J Vet Intern Med"},{"key":"2026021006404422700_jvim15322-bib-0019","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/jvim.12044","article-title":"Fibroblast growth factor 23 in feline chronic kidney disease","volume":"27","author":"Geddes","year":"2013","journal-title":"J Vet Intern Med"},{"key":"2026021006404422700_jvim15322-bib-0020","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.2011.826","article-title":"Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease","volume":"305","author":"Isakova","year":"2011","journal-title":"JAMA"},{"key":"2026021006404422700_jvim15322-bib-0021","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1681\/ASN.2010121224","article-title":"FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis","volume":"22","author":"Kendrick","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"2026021006404422700_jvim15322-bib-0022","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/jama.2011.308","article-title":"Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis","volume":"305","author":"Palmer","year":"2011","journal-title":"JAMA"},{"key":"2026021006404422700_jvim15322-bib-0023","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis","volume":"359","author":"Gutierrez","year":"2008","journal-title":"N Engl J Med"},{"key":"2026021006404422700_jvim15322-bib-0024","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1093\/ndt\/gfp191","article-title":"High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients","volume":"24","author":"Jean","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"2026021006404422700_jvim15322-bib-0025","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1681\/ASN.2010080894","article-title":"Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality","volume":"22","author":"Wolf","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"2026021006404422700_jvim15322-bib-0026","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1002\/jbmr.170","article-title":"FGF-23: more than a regulator of renal phosphate handling?","volume":"25","author":"Juppner","year":"2010","journal-title":"J Bone Miner Res"},{"key":"2026021006404422700_jvim15322-bib-0027","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S1047-2797(02)00251-X","article-title":"Factors associated with improved short term survival in obese end stage renal disease patients","volume":"13","author":"Glanton","year":"2003","journal-title":"Ann Epidemiol"},{"key":"2026021006404422700_jvim15322-bib-0028","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1053\/j.ajkd.2007.02.277","article-title":"Paradoxical association between body mass index and mortality in men with CKD not yet on dialysis","volume":"49","author":"Kovesdy","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"2026021006404422700_jvim15322-bib-0029","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1046\/j.1523-1755.1999.00615.x","article-title":"Body weight-for-height relationships predict mortality in maintenance hemodialysis patients","volume":"56","author":"Kopple","year":"1999","journal-title":"Kidney Int"},{"key":"2026021006404422700_jvim15322-bib-0030","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0272-6386(12)70364-5","article-title":"Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities","volume":"15","author":"Lowrie","year":"1990","journal-title":"Am J Kidney Dis"},{"key":"2026021006404422700_jvim15322-bib-0031","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3945\/ajcn.2008.27390","article-title":"Outcome predictability of biomarkers of protein-energy wasting and inflammation in moderate and advanced chronic kidney disease","volume":"90","author":"Kovesdy","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"2026021006404422700_jvim15322-bib-0032","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1748-5827.1998.tb03613.x","article-title":"Feline chronic renal failure: calcium homeostasis in 80 cases diagnosed between 1992 and 1995","volume":"39","author":"Barber","year":"1998","journal-title":"J Small Anim Pract"},{"key":"2026021006404422700_jvim15322-bib-0033","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1748-5827.1998.tb03598.x","article-title":"Feline chronic renal failure: clinical findings in 80 cases diagnosed between 1992 and 1995","volume":"39","author":"Elliott","year":"1998","journal-title":"J Small Anim Pract"},{"key":"2026021006404422700_jvim15322-bib-0034","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1748-5827.2006.00200.x","article-title":"Association of laboratory data and death within one month in cats with chronic renal failure","volume":"47","author":"Kuwahara","year":"2006","journal-title":"J Small Anim Pract"},{"key":"2026021006404422700_jvim15322-bib-0035","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.2460\/ajvr.1992.53.12.2264","article-title":"Effects of dietary phosphorus and protein in dogs with chronic renal failure","volume":"53","author":"Finco","year":"1992","journal-title":"Am J Vet Res"},{"key":"2026021006404422700_jvim15322-bib-0036","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1681\/ASN.V1101169","article-title":"Beneficial effects of dietary mineral restriction in dogs with marked reduction of functional renal mass","volume":"1","author":"Brown","year":"1991","journal-title":"J Am Soc Nephrol"}],"container-title":["Journal of Veterinary Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjvim.15322","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/32\/6\/1977\/66838751\/jvim15322.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/32\/6\/1977\/66838751\/jvim15322.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T11:40:58Z","timestamp":1770723658000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jvim\/article\/32\/6\/1977\/8471034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,1]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,11,1]]}},"URL":"https:\/\/doi.org\/10.1111\/jvim.15322","relation":{},"ISSN":["1939-1676"],"issn-type":[{"value":"1939-1676","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,11]]},"published":{"date-parts":[[2018,11,1]]},"assertion":[{"value":"2018-01-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-08-13","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-10-16","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}